Outcome of Board Meeting
Wanbury Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 29, 2016, inter alia, has considered and approved the following:- Grant of Employee Stock Option Plan (ESOP) to the extent of 3,00,000 equity shares to the employee/s of the Company.The Meeting of the Board of Directors commenced at 03:30 P.M and concluded at 06:15 P.M. Standalone Financial Results, Limited Review Report for September 30, 2016
Wanbury Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 2016 Postponement of Board Meeting
Wanbury Ltd has informed BSE about Postponement of Board Meeting for approving the Un-audited Financial Results of the Company for the second quarter ended September 30, 2016. Wanbury Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Wanbury Ltd with respect news article appearing in The Economic Times on October 27, 2016 titled "Wanbury Pharma Gets Show Cause Notice from Thane FDA."Wanbury Ltd response is enclosed. Clarification sought from Wanbury Ltd
The Exchange has sought clarification from Wanbury Ltd with respect to news article appearing in The Economic Times on October 27, 2016 titled "Wanbury Pharma Gets Show Cause Notice from Thane FDA."The reply is awaited. Clarifies on news item
With reference to news reported in Economic Times dated October 24, 2016 stating "Pharma Co Wanbury Under FDA Scanner", Wanbury Ltd has submitted to BSE a copy of Clarification is enclosed. Clarification sought from Wanbury Ltd
The Exchange has sought clarification from Wanbury Ltd on October 24, 2016, with reference to news reported in Economic Times dated October 24, 2016 stating "Pharma Co Wanbury Under FDA Scanner"The reply is awaited. Board Meeting Intimation for Results & Closure of Trading Window
Wanbury Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on November 08, 2016, inter alia, to consider and approve the Un-audited Financial Results for the Second quarter and half year ended September 30, 2016.Further, the trading window in respect of the Companys Securities shall remain closed for all Directors/Officers/Designated Employees of the Company from November 01, 2016 till... Shareholding for the Period Ended September 30, 2016
Wanbury Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Wanbury Ltd has informed BSE regarding the details of Voting results at the 28th Annual General Meeting (AGM) of the Company held on September 29, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report.